Active ingredient
Somapacitan
3 finished FDA listings contain Somapacitan as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- SOMAPACITAN
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 10 mg/ml · 3.3 mg/ml · 6.7 mg/ml
- Brand names in FDA listings
- Sogroya
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2557373
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761156 | NOVO NORDISK INC | 2020-08-28 | 3 |
Official labeling on DailyMed
- SOGROYA (SOMAPACITAN-BECO) INJECTION, SOLUTION [NOVO NORDISK] · version 8 · 2026-03-16
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.